Alastair Garfield

Insider Reports History

Entity
Individual
Location
C/O Rhythm Pharmaceuticals, 222 Berkeley Street, Suite 1200, Boston, MA
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Alastair Garfield
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alastair Garfield:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RHYTHM PHARMACEUTICALS, INC. Chief Scientific Officer Restricted Stock Units 26.7K $1.52M $57.22 Feb 14, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. Chief Scientific Officer Stock Option (right to buy) 53.3K Jul 8, 2024 Direct
RHYTHM PHARMACEUTICALS, INC. Chief Scientific Officer Stock Options (Right to Buy) 40K Feb 14, 2025 Direct

Insider Reports Filed by Alastair Garfield

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 14, 2025 2 $0 4 Feb 19, 2025 Chief Scientific Officer
RYTM RHYTHM PHARMACEUTICALS, INC. Jul 8, 2024 2 $0 4 Jul 10, 2024 Chief Scientific Officer
RYTM RHYTHM PHARMACEUTICALS, INC. Jul 8, 2024 0 $0 3 Jul 10, 2024 Chief Scientific Officer